Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial - Neuschwander-Tetri, BA; Loomba, R; Sanyal, AJ (Lancet, 2015)
et al.